Myriad Genetics and Cephalon enter agreement for mutation testing in phase I/II study April 2, 2012 No Comments
Endocyte receives approval for nonproprietary names of anticancer drug and companion imaging agent March 26, 2012 No Comments
First patient enrolled in phase I/II study of PET imaging agent for brain cancer March 21, 2012 No Comments
RSS